The Financial Express6h
US govt grants Moderna $590 million to make bird flu vaccine
The risk to the general public from bird flu is low, and there has been no further evidence of person to person spread, ...
WFAE13h
U.S. pays $590 million to Moderna to speed up development of bird flu vaccine
The public health risk remains low, but bird flu variants have proven to be unpredictable, which is why the virus is a top priority for the federal government.
Georgia halts poultry sales; HHS allocates $590M for flu vaccines
Georgia officials halted all in-state poultry sales, and the U.S. Department of Health and Human Services awarded $590 ...
WBAL22h
Moderna awarded $590M to help accelerate development of mRNA-based bird flu vaccine
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...
US health dept providing Moderna $590 mn to speed mRNA bird flu vaccine
US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, ...
Moderna awarded $590M to help accelerate development of mRNA-based bird flu vaccine: HHS
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...
Moderna Gets $590 Million of Federal Funding For Bird Flu Vaccine — Update
Moderna secured a $590 million package from the U.S. Health and Human Services Department to accelerate the development of its bird influenza vaccine as concerns about a bird flu pandemic in humans ...
As bird flu concerns grow, scientists race to develop new vaccines
As fears grow of a possible bird flu pandemic in humans, the federal government is pouring more money into the development of ...
HHS invests nearly $600 million in Moderna’s bird flu vaccine development
The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...
Becker's Hospital Review1d
$800M+ vaccine investment aims to boost pandemic readiness
HHS is investing more than $800 million in vaccine development and manufacturing capacity to strengthen the nation's response capabilities to emerging infectious disease threats, including bird flu.